Skip to main content

Table 1 Clinical status, demographic information, disease duration, neuropathological staging and APOE genotype of control and AD cases used in this study.

From: Neuroinflammation in Alzheimer's disease wanes with age

Case Diagnosis Sex Age (years) Duration (years) GDS Braak Brain weight (grs) PMD (hours: minutes) APOE genotype
1 CTRL F 52   0 0 1268 6:50 3-3
2 CTRL M 53   0 0 1341 14:25 3-3
3 CTRL F 64   0 0 1169 8:35 4-2
4 CTRL M 70   0 0 1560 7:45 4-3
5 CTRL F 72   0 1 1296 6:45 4-3
6 CTRL M 73   0 0 1267 24:45 3-3
7 CTRL F 76   0 1 1212 4:50 3-2
8 CTRL F 77   0 2 1213 9:15 4-3
9 CTRL M 78   0 1 1467 5:35 4-3
10 CTRL F 78   0 1 1047 6:30 4-3
11 CTRL M 78   0 1 1332 6:55 3-3
12 CTRL M 79   0 1 1334 7:40 4-3
13 CTRL M 82   0 2 1468 13:35 3-3
14 CTRL F 82   0 1 1280 5:30 3-2
15 CTRL F 83   0 2 1102 7:45 3-3
16 CTRL F 85   0 3 1199 9:00 4-3
17 CTRL F 88   0 2 1152 5:40 3-3
18 CTRL F 92   0 1 1031 7:15 3-2
19 CTRL M 98   0 1 1203 8:40 3-3
20 AD F 65 16 7 6 1115 5:40 3-3
21 AD M 67 ? 6 5 1170 5:22 4-4
22 AD F 70 10 7 6 1020 4:30 3-3
23 AD F 76 12 7 6 1170 5:30 4-3
24 AD M 78 8 6 5 1298 7:45 4-4
25 AD F 80 ? 7 6 946 5:20 4-4
26 AD M 80 9 5 6 1240 4:20 4-3
27 AD F 82 7 7 5 1013 4:10 4-3
28 AD F 83 5 5 4 1288 5:20 4-3
29 AD F 83 3 6 5 1095 3:45 4-3
30 AD F 86 10 6 4 1158 4:45 4-3
31 AD F 87 2 7 3 976 3:55 4-2
32 AD F 89 2 5 3 1212 4:10 3-3
33 AD F 91 4 4 3 1161 9:35 4-3
34 AD F 91 7 5 4 1101 3:45 4-3
35 AD F 93 10 6 4 943 6:15 3-3
36 AD F 94 4 5 2 1050 3:15 3-3
37 AD F 94 7 6 2 987 6:35 3-3
38 AD F 97 7 7 3 1016 7:00 3-3
  1. CTRL, control case; AD, Alzheimer's disease patient; F, female; M, male; GDS, Global Deterioration Scale; gr, gram; PMD, post-mortem delay.